Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (38)

« Back to Publications

High-intensity focused ultrasound treatment of unresectable soft tissue sarcoma and desmoid tumours - a systematic review.

Chetan M. et al, (2025), Clin Radiol, 87

Imaging and intervention for soft tissue tumours in the era of locoregional therapies and immunotherapy.

Rehman S. et al, (2025), Clin Radiol, 87

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.

Spiers L. et al, (2023), BMC Cancer, 23

Phase-shift Perfluoropentane Nanoemulsions Enhance Pulsed High-intensity Focused Ultrasound Ablation in an Isolated Perfused Liver System and Their Potential Value for Cancer Therapy.

Zhao L-Y. et al, (2022), J Ultrasound Med, 41, 107 - 121

lterations in Immune Response Profile of Tumor-Draining Lymph Nodes after High-Intensity Focused Ultrasound Ablation of Breast Cancer Patients.

Zhu X-Q. et al, (2021), Cells, 10

Oxford's clinical experience in the development of high intensity focused ultrasound therapy.

Prachee I. et al, (2021), Int J Hyperthermia, 38, 81 - 88

Large-Volume Hyperthermia for Safe and Cost-Effective Targeted Drug Delivery Using a Clinical Ultrasound-Guided Focused Ultrasound Device.

Lyon PC. et al, (2021), Ultrasound Med Biol, 47, 982 - 997

Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.

Lyon PC. et al, (2020), Ultraschall Med, 41, 550 - 556

Role of diffusion-weighted imaging in monitoring treatment response following high-intensity focused ultrasound ablation of recurrent sacral chordoma.

Chetan MR. et al, (2019), Radiol Case Rep, 14, 1197 - 1201

Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.

Gray MD. et al, (2019), Radiology, 291, 232 - 238

Planning and Delivery of Ultrasound- Mediated Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial

MIDDLETON MR. et al, (2019), Radiology

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer.

Lyon PC. et al, (2018), Radiol Case Rep, 13, 1259 - 1266

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.

Lyon PC. et al, (2018), Lancet Oncol, 19, 1027 - 1039

High-intensity focused ultrasound in the treatment of breast tumours.

Peek MCL. and Wu F., (2018), Ecancermedicalscience, 12

High-intensity focused ultrasonic ablation of sacral chordoma is feasible: a series of four cases and details of a national clinical trial.

Gillies MJ. et al, (2017), Br J Neurosurg, 31, 446 - 451

Load More